ANVS:Annovis Bio Inc Snapshot | Charting | News | Options
$12.93 NYSE 7:30a ET
April 2 '24 		Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results
     GlobeNewswire
    Full Story →

    Headline News
    Annovis Announces Publication That Supports Understanding of Buntanetap's Mechanism of Action in Humans
    8:00a ET April 1 '24 GlobeNewswire
    Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer's Disease
    7:30a ET March 20 '24 GlobeNewswire
    Annovis Bio Announces Participation in Forum Discussion at AD/PD(TM) 2024
    8:00a ET February 27 '24 GlobeNewswire
    More News →
    Day  1.49%Week  31.3%Month  9.76%More Charting →
    Today, 2:44p ET Thursday April 25 '24. Markets Open.
    Last $12.93
    Day change   1.49%$0.19
    Open $12.55
    Gap at open $0.19
    Previous close $12.74
    Trading volume 226,646
    10 Day avg vol. 253,332
    Shares out. 11.0Mil
    Market cap. $142.4Mil
    Trading activity Above Avg.
    Previous data from yesterday, April 24 '24.

    Historical Price Performance
    3 month   30.47% 
    6 month   61.42% 
    1 year   12.99% 
    2 year   21.29% 

    Earnings
    Previous 12m -$6.12
    Next 12m Estimate -$2.07
    P/E ratio 2.1x
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.